HUP9702149A2 - Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények - Google Patents
Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP9702149A2 HUP9702149A2 HU9702149A HUP9702149A HUP9702149A2 HU P9702149 A2 HUP9702149 A2 HU P9702149A2 HU 9702149 A HU9702149 A HU 9702149A HU P9702149 A HUP9702149 A HU P9702149A HU P9702149 A2 HUP9702149 A2 HU P9702149A2
- Authority
- HU
- Hungary
- Prior art keywords
- intermediates
- compounds
- pipe powder
- preparation
- tachykinin receptor
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000002462 tachykinin receptor antagonist Substances 0.000 title abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical class O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- -1 heterocyclic piperazinone derivatives Chemical class 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Chemical group O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
Abstract
Tachykinin receptőr antagőnista heterőciklikűs piperazinőn-származékők, intermedierjeik, előállításűk és alkalmazásűk, valamint avegyületeket tartalmazó gyógyászati készítmények. A találmány szerintiindőlil-metil-piperazinőn-származékők (1) és intermedierjeik (2)általánős képletében G1-CH2-csőpőrt vagy -C(O)-csőpőrt; Ar1 adőttesetben szűbsztitűált fenil- vagy naftilcsőpőrt; R1 hidrőgénatőm, (c)képletű csőpőrt vagy -(CH2)qAr2 vagy -CH2C(O)Ar2 képletű csőpőrt, ahőlq = 1-4 közötti szám és Ar2 adőtt esetben szűbsztitűált fenil- vagyindőlilcsőpőrt; R2 hidrőgénatőm, alkil- vagy -CHO csőpőrt; R3hidrőgénatőm vagy adőtt esetben szűbsztitűált fenil- vagynaftilcsőpőrt; R5 hidrőgénatőm, alkil- vagy benzilcsőpőrt, és R6hidrőgénatőm, alkőxi-karbőnil- vagy benzil-őxi-karbőnil-csőpőrt. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40478895A | 1995-03-15 | 1995-03-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9702149A2 true HUP9702149A2 (hu) | 1999-06-28 |
HUP9702149A3 HUP9702149A3 (en) | 1999-07-28 |
Family
ID=23601038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702149A HUP9702149A3 (en) | 1995-03-15 | 1996-02-06 | Heterocyclic substituted piperazinone derivatives as tachykinin receptor antagonists, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds |
Country Status (21)
Country | Link |
---|---|
US (2) | US5840726A (hu) |
EP (1) | EP0815105B1 (hu) |
JP (1) | JP3825472B2 (hu) |
KR (1) | KR19980703032A (hu) |
CN (1) | CN1067068C (hu) |
AR (1) | AR002715A1 (hu) |
AT (1) | ATE206421T1 (hu) |
AU (1) | AU697599B2 (hu) |
CA (1) | CA2215333C (hu) |
DE (1) | DE69615670T2 (hu) |
DK (1) | DK0815105T3 (hu) |
ES (1) | ES2164235T3 (hu) |
FI (1) | FI973671A0 (hu) |
HU (1) | HUP9702149A3 (hu) |
IL (1) | IL117453A (hu) |
NO (1) | NO314693B1 (hu) |
NZ (1) | NZ302948A (hu) |
PT (1) | PT815105E (hu) |
TW (1) | TW464647B (hu) |
WO (1) | WO1996028441A1 (hu) |
ZA (1) | ZA961954B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69621831T2 (de) * | 1995-12-18 | 2003-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Piperazinderivative als tachykinin antagonisten |
DE19939910A1 (de) * | 1999-08-23 | 2001-03-01 | Morphochem Ag | Neue Verbindungen, die Tryptase-Aktivität hemmen |
US20040033986A1 (en) * | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
US7456222B2 (en) * | 2002-05-17 | 2008-11-25 | Sequella, Inc. | Anti tubercular drug: compositions and methods |
CN101404986B (zh) * | 2002-05-17 | 2011-09-28 | 赛奎拉公司 | 用于诊断和治疗感染性疾病的组合物和制药方法 |
WO2005034857A2 (en) * | 2003-09-05 | 2005-04-21 | Sequella, Inc. | Methods and compositions comprising diamines as new anti-tubercular therapeutics |
WO2009136965A1 (en) * | 2008-05-06 | 2009-11-12 | Sequella, Inc. | Compositions and methods comprising capuramycin analogues |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3132882A1 (de) * | 1981-08-20 | 1983-03-03 | Cassella Ag, 6000 Frankfurt | Neue piperazinone, ihre herstellung und verwendung |
IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
WO1994003483A1 (en) * | 1992-07-30 | 1994-02-17 | Chiron Corporation | Endothelin receptor-binding compounds |
GB9222486D0 (en) * | 1992-10-26 | 1992-12-09 | Merck Sharp & Dohme | Therapeutic agents |
AU678023B2 (en) * | 1993-05-06 | 1997-05-15 | Aventis Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them |
-
1996
- 1996-02-06 HU HU9702149A patent/HUP9702149A3/hu unknown
- 1996-02-06 AT AT96905333T patent/ATE206421T1/de not_active IP Right Cessation
- 1996-02-06 DE DE69615670T patent/DE69615670T2/de not_active Expired - Lifetime
- 1996-02-06 DK DK96905333T patent/DK0815105T3/da active
- 1996-02-06 CN CN96192564A patent/CN1067068C/zh not_active Expired - Fee Related
- 1996-02-06 CA CA002215333A patent/CA2215333C/en not_active Expired - Fee Related
- 1996-02-06 WO PCT/US1996/001437 patent/WO1996028441A1/en not_active Application Discontinuation
- 1996-02-06 AU AU49306/96A patent/AU697599B2/en not_active Ceased
- 1996-02-06 NZ NZ302948A patent/NZ302948A/en unknown
- 1996-02-06 EP EP96905333A patent/EP0815105B1/en not_active Expired - Lifetime
- 1996-02-06 KR KR1019970706440A patent/KR19980703032A/ko not_active Application Discontinuation
- 1996-02-06 ES ES96905333T patent/ES2164235T3/es not_active Expired - Lifetime
- 1996-02-06 PT PT96905333T patent/PT815105E/pt unknown
- 1996-02-06 JP JP52757896A patent/JP3825472B2/ja not_active Expired - Fee Related
- 1996-03-11 ZA ZA961954A patent/ZA961954B/xx unknown
- 1996-03-12 IL IL11745396A patent/IL117453A/xx not_active IP Right Cessation
- 1996-03-12 TW TW085102987A patent/TW464647B/zh active
- 1996-03-12 AR ARP960101710A patent/AR002715A1/es active IP Right Grant
-
1997
- 1997-06-19 US US08/878,695 patent/US5840726A/en not_active Expired - Lifetime
- 1997-09-12 NO NO19974205A patent/NO314693B1/no unknown
- 1997-09-12 FI FI973671A patent/FI973671A0/fi not_active IP Right Cessation
-
1998
- 1998-04-27 US US09/067,386 patent/US5864045A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0815105B1 (en) | 2001-10-04 |
WO1996028441A1 (en) | 1996-09-19 |
DK0815105T3 (da) | 2002-01-21 |
HUP9702149A3 (en) | 1999-07-28 |
ATE206421T1 (de) | 2001-10-15 |
FI973671A (fi) | 1997-09-12 |
AR002715A1 (es) | 1998-04-29 |
CN1178529A (zh) | 1998-04-08 |
IL117453A (en) | 2000-07-26 |
ES2164235T3 (es) | 2002-02-16 |
NO974205D0 (no) | 1997-09-12 |
TW464647B (en) | 2001-11-21 |
JPH11501917A (ja) | 1999-02-16 |
FI973671A0 (fi) | 1997-09-12 |
CN1067068C (zh) | 2001-06-13 |
EP0815105A1 (en) | 1998-01-07 |
NO314693B1 (no) | 2003-05-05 |
KR19980703032A (ko) | 1998-09-05 |
US5864045A (en) | 1999-01-26 |
CA2215333A1 (en) | 1996-09-19 |
DE69615670T2 (de) | 2002-08-08 |
US5840726A (en) | 1998-11-24 |
NZ302948A (en) | 2001-05-25 |
AU4930696A (en) | 1996-10-02 |
NO974205L (no) | 1997-11-13 |
DE69615670D1 (de) | 2001-11-08 |
CA2215333C (en) | 2002-01-01 |
ZA961954B (en) | 1996-09-17 |
PT815105E (pt) | 2002-03-28 |
AU697599B2 (en) | 1998-10-08 |
MX9706872A (es) | 1997-11-29 |
JP3825472B2 (ja) | 2006-09-27 |
IL117453A0 (en) | 1996-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941987A (fi) | Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset | |
TR199801594A2 (xx) | CCR-3 resept�r antagonistleri. | |
MX9803407A (es) | Derivados de piperazina 1-(1,2-disustituido piperidinil)-4-sustituidos. | |
HUP0303339A2 (hu) | Heteroaril-karbamid neuropeptid Y Y5 receptor antagonisták, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
HUP9802694A1 (hu) | Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
MY117557A (en) | 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives | |
DK0590919T3 (da) | Terapeutiske midler mod Parkinsons sygdom | |
HUP9901209A2 (hu) | Opioid analóg peptid vegyületek, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
HUP0303398A2 (hu) | 1,2-Dihidropiridin-származékok, eljárás előállításukra és alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
WO2002098856A3 (en) | Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists | |
IL102703A (en) | N-sulfonyl indoline derivatives carrying an amide functional group, their preparation and pharmaceutical compositions containing them | |
TR200101155T2 (tr) | 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III | |
MY117680A (en) | 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)- piperidine derivatives | |
NO974734D0 (no) | Arylglycinamidderivater, fremgangsmåte for fremstilling av disse forbindelsene og farmasöytiske blandinger inneholdende slike forbindelser | |
DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
IL106387A (en) | Indole derivatives, their preparation and pharmaceutical compositions containing them | |
TR199801218T2 (xx) | Takikinin antagonistleri olarak N-asil-2-ikameli-4-(Benzimidazolil-ya da imidazopiridinil-ikameli art�klar)-piperidinler. | |
MX9706394A (es) | Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina, especialmente neuroquinina-1. | |
HUP9801950A2 (hu) | 2-(Aril-fenil-amino)-imidazolin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP9702149A2 (hu) | Tachykinin receptor antagonista heterociklikus piperazinonszármazékok, intermedierjeik, előállításuk és alkalmazásuk, valamint a vegyületeket tartalmazó gyógyászati készítmények | |
TR200200125T2 (tr) | Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar. | |
EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
HUP0203622A2 (hu) | Biciklusos vazopresszin agonisták és ezeket tartalmazó gyógyszerkészítmények | |
HUP0102522A2 (hu) | 3',3'-N-bisz-helyettesített makrolid LHRH antagonista vegyületek és alkalmazásuk, eljárás előállításukra, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0401563A2 (hu) | Új piperidinarboxamid-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |